Maruzen Pharmaceuticals Co., Ltd. | Introduction of PPA-based Renewable Energy Power Generation at Miyoshi Plant
Key facts
- Maruzen Pharmaceuticals Co., Ltd. | Introduction of PPA-based Renewable Energy Power Generation at Miyoshi Plant
- Maruzen Pharmaceuticals promotes CO2 reduction by introducing PPA-based renewable energy power generation at its Miyoshi Plant.
- Date: March 29, 2026
Direct answer
Maruzen Pharmaceuticals promotes CO2 reduction by introducing PPA-based renewable energy power generation at its Miyoshi Plant.
- Citation
- Maruzen Pharmaceuticals Co., Ltd. | Introduction of PPA-based Renewable Energy Power Generation at Miyoshi Plant (March 29, 2026)
- Source
- PR Times
- Date
- March 29, 2026
Maruzen Pharmaceuticals promotes CO2 reduction by introducing PPA-based renewable energy power generation at its Miyoshi Plant.
📋 Article Processing Timeline
- 📰 Published: March 29, 2026 at 16:36
- 🤖 AI Analyzed: May 26, 2026 at 21:27 (1396h 50m after Published)
Maruzen Pharmaceuticals Co., Ltd. (Headquarters: Onomichi, Hiroshima; President: Yasuhiro Higurashi) has introduced renewable energy power generation via a PPA (Power Purchase Agreement) at its Miyoshi Plant (Miyoshi, Hiroshima), effective March 2026.
At the Miyoshi Plant, our primary facility for food ingredients, we have been working to reduce greenhouse gas emissions, such as by switching boiler heat sources from heavy oil A to LNG. With the installation of solar panels on the building's roof via PPA, we have converted a portion of our electricity consumption to renewable energy as of March 2026.
This initiative is expected to convert approximately 460,000 kWh of electricity to renewable energy annually, resulting in a reduction of 250 tons of CO2 per year. Additionally, our Shin-Onomichi Plant, which has its own solar panels, reduces CO2 by 88 tons (160,000 kWh) annually, and our Kui Farm reduces CO2 by 32 tons (60,000 kWh) annually.
In the new fiscal year, we plan to introduce PPA at our General Research Institute (Fukuyama, Hiroshima) and transition the electricity used at our Tokyo Branch (Shibuya, Tokyo) to renewable energy.
To achieve our 2030 goal of a 46% reduction in greenhouse gas emissions compared to 2013 levels—a key materiality target—we will continue to strive for emissions reduction across the entire company.
Our Commitment to SDGs and Sustainability
https://www.maruzenpcy.co.jp/company/sustainability/
Company Overview
Trade Name: Maruzen Pharmaceuticals Co., Ltd.
Representative: Yasuhiro Higurashi, President
Address: 14703-10 Mukaihigashi-cho, Onomichi, Hiroshima
Established: July 13, 1949
Business Description: Manufacturing and sales of pharmaceuticals, pharmaceutical material extracts, quasi-drug material extracts, cosmetic material extracts, food additives, food products, food material extracts, health foods, and health food material extracts.
Capital: 98 million yen
URL: https://www.maruzenpcy.co.jp
FAQ
What is Maruzen Pharmaceuticals Co., Ltd. doing to promote renewable energy at its Miyoshi Plant?
Maruzen Pharmaceuticals Co., Ltd. has introduced renewable energy power generation via a PPA (Power Purchase Agreement) at its Miyoshi Plant, effective March 2026, by installing solar panels on the building's roof.
What is the expected annual reduction in CO2 emissions from the Miyoshi Plant's renewable energy initiative?
The initiative at the Miyoshi Plant is expected to result in an annual reduction of 250 tons of CO2 per year, by converting approximately 460,000 kWh of electricity to renewable energy.
Besides the Miyoshi Plant, where else is Maruzen Pharmaceuticals implementing renewable energy initiatives?
Maruzen Pharmaceuticals' Shin-Onomichi Plant reduces CO2 by 88 tons annually with its own solar panels, and Kui Farm reduces CO2 by 32 tons annually. They also plan to introduce PPA at their General Research Institute and transition electricity at their Tokyo Branch to renewable energy in the new fiscal year.
What is Maruzen Pharmaceuticals' overarching goal regarding greenhouse gas emissions by 2030?
Maruzen Pharmaceuticals aims for a 46% reduction in greenhouse gas emissions by 2030, compared to 2013 levels, which is a key materiality target.
When did Maruzen Pharmaceuticals Co., Ltd. establish its business and what are its main business activities?
Maruzen Pharmaceuticals Co., Ltd. was established on July 13, 1949, and its business description includes the manufacturing and sales of pharmaceuticals, various material extracts (pharmaceutical, quasi-drug, cosmetic, food, health food), food additives, food products, and health foods.